Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arpida Ltd
Leadership Change to Enable Arpida to Become a Fully Integrated Pharmaceutical Company
May 9th, 2008
Arpida Ltd. (SWX: ARPN) announced that Dr Jurgen Raths will succeed Dr Khalid Islam as Chief Executive Officer. Dr Jurgen Raths commands extensive knowledge in the commercialisation of drugs for the treatment of severe infections in hospitals and has successfully built and lead the European Critical Care sales, medical and marketing organisation of Eli Lilly and Company for many years. At the Annual General Meeting of 7 May, the Board of Directors will propose to appoint Dr Khalid Islam to the Board of Directors of Arpida Ltd. Dr Islam will work closely with Dr Raths for a seamless transition and will continue thereafter as a consultant for the coming years. As a...
Source: Health Business Week (2008-05-09)
|
